End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- THB | -.--% | -.--% | -.--% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- The company is in a robust financial situation considering its net cash and margin position.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The firm trades with high earnings multiples: 29.06 times its 2024 earnings per share.
- With an enterprise value anticipated at 4.17 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 12.44B | - | ||
-19.03% | 16.53B | B+ | ||
-10.76% | 15.21B | A- | ||
0.00% | 11.22B | B+ | ||
+11.44% | 10.75B | B+ | ||
+7.41% | 8.39B | A- | ||
+22.81% | 7.78B | B | ||
+21.11% | 7.22B | D | ||
+3.61% | 4.64B | - | ||
+39.72% | 4.32B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock
- Equities
- Stock Bangkok Dusit Medical Services
- Stock Bangkok Dusit Medical Services Public Company Limited - Thailand S.E.
- Ratings Bangkok Dusit Medical Services Public Company Limited